Literature DB >> 28700942

A PML/Slit Axis Controls Physiological Cell Migration and Cancer Invasion in the CNS.

Valeria Amodeo1, Deli A1, Joanne Betts1, Stefano Bartesaghi1, Ying Zhang2, Angela Richard-Londt2, Matthew Ellis2, Rozita Roshani1, Mikaella Vouri1, Sara Galavotti1, Sarah Oberndorfer1, Ana Paula Leite1, Alan Mackay3, Aikaterini Lampada1, Eva Wessel Stratford4, Ningning Li2, David Dinsdale5, David Grimwade6, Chris Jones3, Pierluigi Nicotera7, David Michod8, Sebastian Brandner2, Paolo Salomoni9.   

Abstract

Cell migration through the brain parenchyma underpins neurogenesis and glioblastoma (GBM) development. Since GBM cells and neuroblasts use the same migratory routes, mechanisms underlying migration during neurogenesis and brain cancer pathogenesis may be similar. Here, we identify a common pathway controlling cell migration in normal and neoplastic cells in the CNS. The nuclear scaffold protein promyelocytic leukemia (PML), a regulator of forebrain development, promotes neural progenitor/stem cell (NPC) and neuroblast migration in the adult mouse brain. The PML pro-migratory role is active also in transformed mouse NPCs and in human primary GBM cells. In both normal and neoplastic settings, PML controls cell migration via Polycomb repressive complex 2 (PRC2)-mediated repression of Slits, key regulators of axon guidance. Finally, a PML/SLIT1 axis regulates sensitivity to the PML-targeting drug arsenic trioxide in primary GBM cells. Taken together, these findings uncover a drug-targetable molecular axis controlling cell migration in both normal and neoplastic cells.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  PML; Polycomb; Slit; cell migration; glioblastoma; neurogenesis; nuclear lamina

Mesh:

Substances:

Year:  2017        PMID: 28700942     DOI: 10.1016/j.celrep.2017.06.047

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  17 in total

1.  Fibroblast growth factor receptor 1 signaling transcriptionally regulates the axon guidance cue slit1.

Authors:  Jung-Lynn Jonathan Yang; Gabriel E Bertolesi; Carrie L Hehr; Jillian Johnston; Sarah McFarlane
Journal:  Cell Mol Life Sci       Date:  2018-04-28       Impact factor: 9.261

Review 2.  The Role of Metabolic Plasticity in Blood and Brain Stem Cell Pathophysiology.

Authors:  Catherine J Libby; Jonathan McConathy; Victor Darley-Usmar; Anita B Hjelmeland
Journal:  Cancer Res       Date:  2019-10-01       Impact factor: 12.701

3.  Mechanistic insights into anticancer properties of oligomeric proanthocyanidins from grape seeds in colorectal cancer.

Authors:  Preethi Ravindranathan; Divya Pasham; Uthra Balaji; Jacob Cardenas; Jinghua Gu; Shusuke Toden; Ajay Goel
Journal:  Carcinogenesis       Date:  2018-05-28       Impact factor: 4.944

4.  Genome-wide CRISPR knockout screening identified G protein pathway suppressor 2 as a novel tumor suppressor for uveal melanoma metastasis.

Authors:  Shuangshuang Shi; Haojie Chen; Hanqing Wang; JianFeng Wan; Yi Shi; Jia Li; Shuo Wang; Jie Shi; Jianying Lv; Tong Wu; Longlong Wang; Fengyuan Sun
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-08       Impact factor: 4.322

5.  High SOX9 Maintains Glioma Stem Cell Activity through a Regulatory Loop Involving STAT3 and PML.

Authors:  Paula Aldaz; Natalia Martín-Martín; Ander Saenz-Antoñanzas; Estefania Carrasco-Garcia; María Álvarez-Satta; Alejandro Elúa-Pinin; Steven M Pollard; Charles H Lawrie; Manuel Moreno-Valladares; Nicolás Samprón; Jürgen Hench; Robin Lovell-Badge; Arkaitz Carracedo; Ander Matheu
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

Review 6.  The potential of Slit2 as a therapeutic target for central nervous system disorders.

Authors:  Prativa Sherchan; Zachary D Travis; Jiping Tang; John H Zhang
Journal:  Expert Opin Ther Targets       Date:  2020-05-15       Impact factor: 6.902

7.  Kernel Differential Subgraph Analysis to Reveal the Key Period Affecting Glioblastoma.

Authors:  Jiang Xie; Jiamin Sun; Jiatai Feng; Fuzhang Yang; Jiao Wang; Tieqiao Wen; Qing Nie
Journal:  Biomolecules       Date:  2020-02-17

8.  Identification of a Two-Gene (PML-EPB41) Signature With Independent Prognostic Value in Osteosarcoma.

Authors:  Shengye Liu; Jiamei Liu; Xuechen Yu; Tao Shen; Qin Fu
Journal:  Front Oncol       Date:  2020-01-24       Impact factor: 6.244

9.  JAK2V617F myeloproliferative neoplasm eradication by a novel interferon/arsenic therapy involves PML.

Authors:  Tracy Dagher; Nabih Maslah; Valérie Edmond; Bruno Cassinat; William Vainchenker; Stéphane Giraudier; Florence Pasquier; Emmanuelle Verger; Michiko Niwa-Kawakita; Valérie Lallemand-Breitenbach; Isabelle Plo; Jean-Jacques Kiladjian; Jean-Luc Villeval; Hugues de Thé
Journal:  J Exp Med       Date:  2021-02-01       Impact factor: 14.307

10.  PML Differentially Regulates Growth and Invasion in Brain Cancer.

Authors:  Maria Tampakaki; Mariam-Eleni Oraiopoulou; Eleftheria Tzamali; Giorgos Tzedakis; Takis Makatounakis; Giannis Zacharakis; Joseph Papamatheakis; Vangelis Sakkalis
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.